In addition, TP53 mutations, as defined by a diffuse and intense TP53 expression, and RB1 loss, as defined by a lack of expression due to immunohistochemistry, have been associated with small-cell carcinoma morphology [96], which is the prototype of AVPC. Here, TP53 is linked to small cell carcinoma.